Cyclomedica Usa, LLC

Cyclomedica USA, LLC, a foreign-owned medical technology manufacturer headquartered in Tucker, Georgia, supplies specialized nuclear medicine diagnostic equipment and pharmaceutical products to federal healthcare agencies as a prime contractor, competing on full-and-open awards with no small business set-aside designations. The vendor operates exclusively as a prime (100% of recent awards) and does not hold SBA certifications.

Cyclomedica's federal capability portfolio centers on the Technegas diagnostic system—a specialized device for pulmonary and ventilation studies used to detect pulmonary embolism and respiratory diseases—and related pharmaceutical products, particularly Technetium kits for nuclear medicine applications. Recent representative work includes a $200.2 million purchase order from the Defense Health Agency awarded October 1, 2024, for Technetium kits used at Brooke Army Medical Center; a $170.6 million delivery order from Veterans Integrated Service Network 22 for Technegas Plus diagnostic system equipment, awarded August 1, 2026, under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB); and an $84,000 delivery order from Veterans Integrated Service Network 8 for Technegas Plus system rental and access, awarded September 29, 2026, also under FSS-61-IB. These awards reflect the vendor's role as a sole-source supplier—several solicitations explicitly noted that Cyclomedica possesses unique capability to meet specialized requirements.

Customer concentration is heavily weighted to the VA system. The top customer by potential value is the Department of Veterans Affairs National Acquisition Center ($3.2 million from a single Blanket Purchase Agreement for Technegas products, since cancelled in March 2025); the Defense Health Agency ($313 thousand across two awards); Veterans Integrated Service Network 12 ($250 thousand across two awards); and VISN 22, VISN 17, and VISN 8 collectively representing smaller volumes. The National Institutes of Health Clinical Center accounts for two awards totaling $25 thousand. Across all fourteen awards, the top five customers account for 95% of combined potential value, indicating significant customer concentration within federal healthcare procurement. Cyclomedica places work under the GSA Federal Supply Schedule Pharmaceuticals and Drugs (FSS-61-IB), under which five task orders total $330 thousand in combined potential value, and held a single-award Federal Supply Schedule contract with VISN 12 (ceiling $225 thousand, extended through March 14, 2030) that serves as the administrative vehicle for routine pharmaceutical procurements.

Activity has grown from four awards in 2024 to seven in 2026, with combined potential value across all fourteen recent awards totaling $4.2 million. Only one award (valued at approximately $10 thousand) faces ultimate completion inside the next twenty-four months, resulting in minimal recompete exposure in the near term. The vendor previously held a $3.19 million Blanket Purchase Agreement with the National Acquisition Center for Technegas products; that vehicle was cancelled in March 2025, representing a loss of the vendor's largest single IDV. Cyclomedica competes on full-and-open awards without set-aside designations, positioning the company as a niche commercial supplier rather than a small business set-aside holder, and maintains performance locations at its Tucker headquarters, military medical facilities in San Antonio and Bethesda, and VA medical centers across multiple states.